Plain-English translation of NCT05863910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a 2-year research study that follows children who are already using , prescribed by their doctor, to see how it affects their symptoms and quality of life. Researchers will ask you and your child to fill out questionnaires about pain, sleep, mood, behavior, and how the medication is working—without changing your current medical plan. The study is designed to gather real-world information about whether is helping children with epilepsy, cancer, and other conditions.
While some doctors prescribe to children for certain symptoms, there isn't much research showing exactly how well it works in everyday life. This study aims to fill that gap by collecting honest, detailed feedback from families already using this medication, so doctors can better understand its benefits and side effects.
You likely qualify if…
You likely don't qualify if…
You would complete online questionnaires about your child's symptoms and how the medication is affecting them at regular intervals: 3 weeks, 6 weeks, 12 weeks, 18 weeks, and then at 6 months, 12 months, 18 months, and 24 months. Questions cover pain, sleep, mood, behavior, and specific concerns related to your child's condition (such as seizure counts if they have epilepsy, or symptom burden if they have cancer). The study doesn't involve clinic visits or changes to your child's current treatment plan—it's purely observational.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Canada
University of Manitoba
Collaborators
The Canadian Collaborative for Childhood Cannabinoid Therapeutics, Canadian Cancer Society (CCS)
Enrollment target
~500 participants
Started
November 2023
Primary completion
December 2027
Age range
3 Years – 17 Years
Last updated on clinicaltrials.gov in November 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lauren E Kelly, PhD
University of Manitoba
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.